Production (Stage)
ICU Medical, Inc.
ICUI
$128.99
-$1.74-1.33%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 6.71% | 7.14% | 6.47% | 8.58% | -0.35% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.71% | 7.14% | 6.47% | 8.58% | -0.35% |
| Cost of Revenue | 3.46% | -3.30% | 4.03% | 8.98% | 1.28% |
| Gross Profit | 13.42% | 32.45% | 11.38% | 7.85% | -3.54% |
| SG&A Expenses | -0.27% | 2.74% | 9.49% | 5.74% | 3.33% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.53% | -1.61% | 5.41% | 7.88% | 2.18% |
| Operating Income | 414.97% | 946.11% | 46.23% | 28.01% | -70.85% |
| Income Before Tax | 70.34% | 122.40% | -234.10% | 14.57% | -174.61% |
| Income Tax Expenses | 69.07% | 264.05% | 219.45% | 114.49% | 175.57% |
| Earnings from Continuing Operations | 60.79% | -38.96% | -555.69% | -115.48% | -302.27% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 60.79% | -38.96% | -555.69% | -115.48% | -302.27% |
| EBIT | 414.97% | 946.11% | 46.23% | 28.01% | -70.85% |
| EBITDA | 28.98% | 91.52% | 5.47% | 4.15% | -18.79% |
| EPS Basic | 61.30% | -36.97% | -550.05% | -112.68% | -298.83% |
| Normalized Basic EPS | 128.79% | 144.51% | 63.37% | 56.70% | -629.18% |
| EPS Diluted | 61.31% | -38.15% | -550.15% | -113.28% | -297.56% |
| Normalized Diluted EPS | 128.79% | 144.51% | 63.00% | 56.70% | -629.18% |
| Average Basic Shares Outstanding | 1.31% | 1.46% | 1.27% | 1.32% | 0.87% |
| Average Diluted Shares Outstanding | 1.31% | 1.46% | 0.29% | 1.32% | 0.87% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |